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The practice and timing of routine antenatal visits for healthy pregnant women, introduced arbitrarily and without
evidence of effectiveness, have become entrenched in obstetric practice over the last century. In 2001 the large,
cluster randomized WHO Antenatal Care Trial concluded that a goal-orientated package of antenatal care with
reduced visits seemed not to affect maternal and perinatal outcomes. The reduced visit package has been
implemented in several countries. The current re-analysis finds that the significantly increased perinatal mortality
which occurred in the reduced visit package persists after adjustment for potential confounding factors. The WHO
Antenatal Care Trial provided the first evidence from a randomized trial that the traditional high frequency of
routine visits in the third trimester may well reduce perinatal mortality.Routine antenatal care visits for healthy pregnant women
were introduced in Europe [1] and North America [2] al-
most a century ago on the unproven assumption that they
would improve outcomes for mother and baby. Repeated
visits by healthy women to a health facility represent a
substantial intrusion in women’s daily lives, and it would
be useful to have evidence of benefit with which to justify
our expectations of compliance. The practice has become
so entrenched that randomized trials of antenatal care ver-
sus no antenatal care are unlikely to be undertaken.
In 2001 the results of a landmark trial comparing a pack-
age of antenatal care with reduced, goal-orientated visits
versus standard antenatal care were published in The
Lancet [3]. Although perinatal mortality was increased in
the reduced visit package (234/11672, 2.0% versus 190/
11121, 1.7%), the conclusion arrived at by the authors was* Correspondence: justhof@gmail.com
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distribution, and reproduction in any mediumthat provision of antenatal care by the new model seemed
not to affect maternal and perinatal outcomes.
This paper and derivative publications such as the WHO
manual for the implementation of the new model (http://
www.who.int/reproductivehealth/publications/maternal_
perinatal_health/RHR_01_30/en/index.html) have im-
pacted on antenatal care practice in low-income countries
such as Thailand [4], South Africa (http://www.doh.gov.za/
docs/stratdocs/2012/MNCWHstratplan.pdf) and possibly
Nigeria [5].
The authors of the current paper are to be commended
for undertaking this re-analysis of the WHO antenatal
care trial data. The crude risk ratio (95% confidence inter-
val) for the perinatal mortality rates indicated above
was 1.20 (1.04, 1.38). After adjustment for potential
confounding factors, the risk ratio remained signifi-
cantly increased at 1.18 (1.01, 1.37). They point out
that the increased risk of fetal death between 32 and
36 weeks gestation could be due to reduced number of
visits, heterogeneity in study populations or differencesd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Hofmeyr and Hodnett Reproductive Health 2013, 10:20 Page 2 of 2
http://www.reproductive-health-journal.com/content/10/1/20in quality of care. The fact that perinatal mortality was
not a primary outcome of the trial increases the possi-
bility that the ‘statistically significant’ difference in
perinatal mortality might have occurred by chance.
However, given that this was a large, well-designed
cluster randomized trial (24 000 women studied in 53
randomized clusters) which sought to minimize the
possibility of confounding factors, that the current re-
analysis was robust after adjustment for potential
confounding factors, and that the increase in perinatal
mortality is consistent with trends in the two other
cluster randomized trials conducted in Zimbabwe [6],
we find the evidence, that a reduced number of ante-
natal visits is associated with increased perinatal mor-
tality, compelling.
A link between number of antenatal visits and peri-
natal mortality is certainly plausible. Asymptomatic con-
ditions such as pre-eclampsia, fetal growth restriction
and unexplained intrauterine death may present unex-
pectedly in the third trimester, and an increased number
of routine visits may detect these conditions earlier, or
elicit a report of reduced fetal movements earlier, allowing
more timely intervention.
This paper provides sound information to guide the
decisions of policymakers regarding the number of ante-
natal visits which should be offered with the available re-
sources. The importance of the content of routine
antenatal care should not be lost, when decisions are
made about numbers of visits. The two are (or should
be) inextricably linked, as they were in the original trial
report [3].
Most importantly, after a century of blind faith, this
paper provides probably the first direct evidence from a
randomized trial that routine antenatal visits for healthy
pregnant women do make a difference.
Author details
1Effective Care Research Unit, University of the Witwatersrand/Fort Hare,
Eastern Cape Department of Health, Eastern Cape, South Africa. 2Lawrence S.
Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada.
Received: 1 March 2013 Accepted: 1 March 2013
Published: 12 April 2013References
1. Oakley A: The origins and development of antenatal care. In Effectiveness
and satisfaction in antenatal care. Clinics in Developmental Medicine Nos.
81/82. Edited by Enkin M, Chalmers I. Spastics International Medical
Publications; 1982:1–21.
2. Alexander GR, Kotelchuck M: Assessing the role and effectiveness of
prenatal care: History, challenges, and directions for future research.
Public Health Rep 2001, 116:306–306.
3. Villar J, Ba'aqeel H, Piaggio G, Lumbiganon P, Miguel Belizan J, Farnot U, Al
Mazrou Y, Carroli G, Pinol A, Donner A, Langer A, Nigenda G, Mugford M,
Fox-Rushby J, Hutton G, Bergsjo P, Bakketeig L, Berendes H, Garcia J, WHO
Antenatal Care Trial Research Group: WHO antenatal care randomised trial
for the evaluation of a new model of routine antenatal care. Lancet 2001,
357:1551–1564.4. Lumbiganon P, Winiyakul N, Chongsomchai C, Chaisiri K: From research to
practice: the example of antenatal care in Thailand. Bull World Health
Organ 2004, 82(10):746–9.
5. Umeora OU, Sunday-Adeoye I, Ugwu GO: Advocating the new WHO
antenatal care model in a free maternity care setting in a developing
country. Trop Doct 2008, 38(1):24–7. doi:10.1258/td.2007.004403.
6. Dowswell T, Carroli G, Duley L, Gates S, Gülmezoglu AM, Khan-Neelofur D,
Piaggio GGP: Alternative versus standard packages of antenatal care for
low-risk pregnancy. Cochrane Database Syst Rev 2010, (10):CD000934.
doi:10.1002/14651858.
doi:10.1186/1742-4755-10-20
Cite this article as: Hofmeyr and Hodnett: Antenatal care packages with
reduced visits and perinatal mortality: a secondary analysis of the WHO
antenatal care trial - Comentary: routine antenatal visits for healthy
pregnant women do make a difference. Reproductive Health 2013 10:20.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
